Biomerica Inc.
BMRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.22M
Close$
$1.41
13.4% downside
Current Fair Value
13.4% downsideOvervalued by 13.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.22 Million |
|---|---|
| Enterprise Value | $4.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.16 |
| Beta | 0.33 |
| Outstanding Shares | 3,010,308 |
Return
| Return on Equity | -125.84% |
|---|---|
| Return on Assets | -85.57% |
| Return on Invested Capital | -125.78% |
Valuation & Multiples
| P/E Ratio | -1.61 |
|---|---|
| PEG | -12.6 |
| Price to Sales | 1.63 |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 0.95 |
| Enterprise Value to EBIT | -0.99 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 14, 2026
EPS Estimate
$-1.20
Average shareholder expectationRevenue Estimate
$3.63 M
Average shareholder expectationNext Earnings Call
Expected Date
August 27, 2026
EPS Estimate
$-1.20
Average shareholder expectationRevenue Estimate
$3.63 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.71%▲ 0.64% |
|---|---|
| Total Invested | $236,107▲ 4.74% |
| Investors Holding | 11▼ 2.00% |
ESG Score
No data